AMG 232 (KRT-232)

1 1

Selleck Chemicals

S7426-5MG

€265,00 EUR
€265,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
View full details

AMG 232 (KRT-232) is an inhibitor of MDM2 and MDMX and related targets used in studies of Apoptosis. In practice, this places the compound in experiments that measure caspase-associated cell-death signaling and survival decisions in apoptosis, cancer, and cell cycle models.

By inhibiting MDM2 and MDMX and related targets, AMG 232 (KRT-232) can be used to examine caspase-associated cell-death signaling and survival decisions. This context is compatible with apoptosis, viability, and caspase-readout assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In apoptosis, cancer, and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving MDM2 and MDMX and related targets
  • Pathway perturbation studies connected to Apoptosis
  • Concentration-response inhibition and target-dependence studies
  • Phenotypic profiling in apoptosis, cancer, and cell cycle models

Overall, AMG 232 (KRT-232) is appropriate when a defined chemical perturbant is needed to connect MDM2 and MDMX and related targets with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
MDM2 • MDMX • p53
Target Class:
Other
Pathways:
Apoptosis
Research Area:
Apoptosis • Cancer • Cell Cycle
CAS No.:
1352066-68-2
Molecular Weight:
568.55
Formula:
C₂₈H₃₅Cl₂NO₅S
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.